Novo Holdings Galecto, Inc. Transaction History
Novo Holdings
- $1.4 Billion
- Q2 2024
A detailed history of Novo Holdings transactions in Galecto, Inc. stock. As of the latest transaction made, Novo Holdings holds 2,497,791 shares of GLTO stock, worth $28.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,497,791
Previous 2,497,791
-0.0%
Holding current value
$28.5 Million
Previous $1.17 Million
-0.0%
% of portfolio
0.08%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding GLTO
# of Institutions
25Shares Held
4.04MCall Options Held
100Put Options Held
100-
Jim Simons Renaissance Technologies LLC | New York, Ny579KShares$6.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA221KShares$2.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$2.45 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA168KShares$1.92 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il129KShares$1.47 Million0.0% of portfolio
About Galecto, Inc.
- Ticker GLTO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,395,700
- Market Cap $290M
- Description
- Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...